{"id":50637,"date":"2023-09-20T09:10:58","date_gmt":"2023-09-20T09:10:58","guid":{"rendered":"https:\/\/medsname.com\/glycomet-gp\/"},"modified":"2026-06-21T06:34:21","modified_gmt":"2026-06-21T06:34:21","slug":"glycomet-gp","status":"publish","type":"product","link":"https:\/\/medsbase.com\/glycomet-gp\/","title":{"rendered":"Glycomet-GP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Glycomet-GP?<\/h3>\n<p style=\"margin:0;\"><strong>Glycomet-GP<\/strong> is a fixed-dose combination tablet containing <strong><a href=\"https:\/\/medsbase.com\/glycimep-glimepiride-guide\/\">Glimepiride<\/a> (1 mg or 2 mg)<\/strong> and <strong>metformin (500 mg)<\/strong> for the treatment of <strong>type&nbsp;2 diabetes<\/strong>. It combines two complementary mechanisms in a single tablet: metformin reduces the liver&rsquo;s glucose output and improves insulin sensitivity, while glimepiride stimulates the pancreas to release more insulin. Usual dose is one tablet twice daily with breakfast and dinner. Typical HbA1c reduction: <strong>1.5&ndash;2.0 percentage points<\/strong>. Main side effects: GI upset from metformin (first 1&ndash;2 weeks) and hypoglycaemia from the sulfonylurea. Glimepiride is a third-generation sulfonylurea with lower hypoglycaemia risk than glibenclamide. Avoid in severe renal impairment (eGFR &lt; 30), decompensated heart failure, acute illness with dehydration, and sulfa allergy.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>What you get with MedsBase:<\/strong> WHO-GMP certified manufacturer \u00b7 Discreet packaging \u00b7 Worldwide shipping \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/reviews\/\">customer reviews<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Every order is covered by our <a href=\"https:\/\/medsbase.com\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n<h3>Why order from MedsBase<\/h3>\n<p>Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging \u2014 no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor \u2014 never &ldquo;MedsBase&rdquo; or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Glycomet-GP?<\/h2>\n<p>Glycomet-GP is a <strong>fixed-dose combination (FDC)<\/strong> oral antidiabetic medicine containing two active ingredients: <strong>Glimepiride (1 mg or 2 mg)<\/strong> and <strong>metformin hydrochloride (500 mg)<\/strong>, manufactured by USV Pharma. Available in packs of 30, 60, 90 or 180 tablets.<\/p>\n<p>Combination tablets simplify the regimen (one tablet instead of two), improve adherence, and are typically less expensive than the two components bought separately. Glycomet-GP is usually prescribed when metformin monotherapy is not achieving HbA1c targets.<\/p>\n<h2 class=\"wp-block-heading\">How Does Glycomet-GP Work?<\/h2>\n<p>The two components attack hyperglycaemia from different angles &mdash; this is why combination therapy is more effective than up-titrating either drug alone:<\/p>\n<ul>\n<li><strong>Metformin<\/strong> &mdash; reduces hepatic glucose production (by up to one third), improves peripheral insulin sensitivity in muscle and fat, and modestly slows intestinal glucose absorption. It does <em>not<\/em> stimulate insulin release and does not cause hypoglycaemia on its own.<\/li>\n<li><strong>Glimepiride<\/strong> &mdash; closes ATP-sensitive potassium channels on pancreatic beta cells, depolarising them and triggering calcium-mediated <strong>insulin release<\/strong>. This works only while the beta cells still produce insulin (early-to-mid type&nbsp;2 diabetes).<\/li>\n<\/ul>\n<p>Together, the two mechanisms produce an HbA1c fall of <strong>1.5&ndash;2.0 percentage points<\/strong>, substantially more than metformin monotherapy.<\/p>\n<h2 class=\"wp-block-heading\">Dosage and Administration<\/h2>\n<p><strong>Starting dose:<\/strong> One tablet of Glycomet-GP with the main meal (breakfast). If glycaemia is not controlled after 2&ndash;4 weeks, increase to one tablet twice daily &mdash; with breakfast and dinner.<\/p>\n<ul>\n<li><strong>Take with or immediately after food<\/strong> &mdash; reduces metformin GI side effects and matches the sulfonylurea&rsquo;s action to the post-meal glucose rise.<\/li>\n<li><strong>Titrate slowly.<\/strong> Gradual dose increases reduce both GI upset and hypoglycaemia.<\/li>\n<li><strong>Do not double up on a missed dose.<\/strong> Skip the missed dose; take the next at the normal time.<\/li>\n<li><strong>Before surgery, IV contrast, or acute illness<\/strong> &mdash; hold the medicine and contact your doctor.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Side Effects<\/h2>\n<p><strong>From the metformin component (usually in the first 1&ndash;2 weeks):<\/strong><\/p>\n<ul>\n<li>Diarrhoea, nausea, abdominal cramps, flatulence<\/li>\n<li>Metallic taste in the mouth<\/li>\n<li>Loss of appetite<\/li>\n<\/ul>\n<p><strong>From the sulfonylurea component:<\/strong><\/p>\n<ul>\n<li><strong>Hypoglycaemia<\/strong> &mdash; shakiness, sweating, palpitations, hunger, confusion. Treat with 15&nbsp;g fast-acting carbohydrate. Higher risk in older adults, missed meals, and renal impairment.<\/li>\n<li>Modest weight gain (1&ndash;3 kg)<\/li>\n<li>Occasional skin rash<\/li>\n<\/ul>\n<p><strong>Uncommon but serious:<\/strong><\/p>\n<ul>\n<li>Lactic acidosis (from metformin) &mdash; very rare, almost always in the setting of acute kidney injury, sepsis, or hypoxia<\/li>\n<li>Vitamin B12 deficiency (long-term metformin) &mdash; check annually<\/li>\n<li>Severe hypoglycaemia &mdash; may require medical intervention, especially in elderly or renal impairment<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Drug Interactions<\/h2>\n<p><strong>Raise hypoglycaemia risk:<\/strong> insulin, other antidiabetics, alcohol (especially binge), trimethoprim\/sulfamethoxazole, fluconazole, clarithromycin, ACE inhibitors, high-dose salicylates, non-selective beta-blockers (which also mask hypo symptoms), MAOIs.<\/p>\n<p><strong>Raise lactic acidosis risk (metformin):<\/strong> IV iodinated contrast, carbonic anhydrase inhibitors (acetazolamide, topiramate), cationic drugs (cimetidine, dolutegravir, ranolazine).<\/p>\n<p><strong>Reduce glucose-lowering effect:<\/strong> corticosteroids, thiazide diuretics, thyroid hormones, phenytoin, rifampicin, atypical antipsychotics, oral contraceptives.<\/p>\n<h2 class=\"wp-block-heading\">Who Should Not Take Glycomet-GP?<\/h2>\n<ul>\n<li>Type&nbsp;1 diabetes mellitus, diabetic ketoacidosis<\/li>\n<li>Severe renal impairment (eGFR &lt; 30&nbsp;mL\/min\/1.73&nbsp;m&sup2;)<\/li>\n<li>Acute or unstable heart failure<\/li>\n<li>Severe hepatic impairment<\/li>\n<li>Sulfonamide (sulfa) allergy<\/li>\n<li>Acute illness with risk of tissue hypoxia &mdash; sepsis, respiratory failure, recent MI<\/li>\n<li>Pregnancy and breastfeeding &mdash; insulin is preferred<\/li>\n<li>Before and 48 hours after IV iodinated contrast imaging (if eGFR &lt; 60)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Storage<\/h2>\n<p>Store Glycomet-GP below 25&deg;C in a dry place, in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Frequently Asked Questions<\/h2>\n<h3 class=\"wp-block-heading\">Is Glycomet-GP the same as taking metformin and glimepiride separately?<\/h3>\n<p>Clinically, yes &mdash; the fixed-dose combination delivers the same active ingredients at the same doses as the two tablets taken together. The advantage is fewer pills, better adherence, and typically lower cost. The trade-off is less dose flexibility: if either component needs changing, the FDC has to be swapped for the separate tablets.<\/p>\n<h3 class=\"wp-block-heading\">When is Glycomet-GP usually added to a diabetes regimen?<\/h3>\n<p>When metformin monotherapy at maximum tolerated dose is no longer controlling HbA1c. Most guidelines (ADA, EASD, NICE) recommend adding a second agent when HbA1c is &gt; 7.5% on metformin alone. A sulfonylurea is a widely used second-line option because it is inexpensive and effective, although DPP-4 inhibitors and SGLT-2 inhibitors are now preferred in people with cardiovascular or renal comorbidities.<\/p>\n<h3 class=\"wp-block-heading\">Can Glycomet-GP cause low blood sugar (hypoglycaemia)?<\/h3>\n<p>Yes &mdash; because it contains a sulfonylurea. Skipping meals, unusual exercise, alcohol, and certain drug interactions raise the risk. Always take Glycomet-GP with food and carry fast-acting carbohydrate. Severe or prolonged hypoglycaemia needs medical review.<\/p>\n<h3 class=\"wp-block-heading\">Will Glycomet-GP cause weight gain?<\/h3>\n<p>Modest weight gain (1&ndash;3 kg) is common because of the sulfonylurea component. Metformin is weight-neutral or slightly weight-reducing, so the FDC usually causes less gain than sulfonylurea monotherapy.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol while taking Glycomet-GP?<\/h3>\n<p>Moderate alcohol with food is generally safe. Avoid binge drinking and alcohol on an empty stomach &mdash; both raise hypoglycaemia risk (from the sulfonylurea) and lactic acidosis risk (from metformin).<\/p>\n<h3 class=\"wp-block-heading\">Do I still need to check my blood sugar?<\/h3>\n<p>Yes, particularly in the first 2&ndash;4 weeks, after dose changes, or during illness. HbA1c should be checked every 3&ndash;6 months.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Glycomet-GP online?<\/h3>\n<p>You can order Glycomet-GP (500\/1 mg or 500\/2 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Related Diabetes Medications<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/glycomet-sr\/\">Glycomet SR &mdash; Metformin sustained-release<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/amaryl\/\">Amaryl &mdash; Glimepiride 1\/2\/4 mg (Sanofi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/januvia\/\">Januvia &mdash; Sitagliptin (DPP-4 inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/jardiance-empagliflozin\/\">Jardiance &mdash; Empagliflozin (SGLT-2 inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/forxiga-dapagliflozin\/\">Forxiga &mdash; Dapagliflozin (SGLT-2 inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/janumet\/\">Janumet &mdash; Sitagliptin + Metformin combo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/diabetes-medication\/\"><strong>Browse all Diabetes Medications<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>&#9877; Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Sulfonylurea + metformin combinations can cause hypoglycaemia and (rarely) lactic acidosis &mdash; always use under medical guidance with regular blood glucose, renal function, and vitamin B12 monitoring.<\/div>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-diabetes-starter-pack\">Many patients reach Glycomet-GP only after starting on metformin monotherapy; if you&#8217;re newly diagnosed or want both first-line and step-up therapy bundled, our <a href='\/diabetes-starter-pack\/'>Diabetes Starter Pack (Glycomet SR 1000 mg + Glycomet-GP)<\/a> ships the ADA\/EASD-aligned starter regimen in one parcel.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Related Alternatives<\/h3>\n<p>Other products in <strong>Chronic Conditions<\/strong> that customers also view:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/methylene-blue-injection\/\">Methylene Blue Injection<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/leptomate\/\">Leptomate<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/modin-2-5\/\">Modin 2.5<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hydrosar\/\">Hydrosar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/crestor\/\">Crestor<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<h5>\u2705 Dual-action diabetes management<br \/>\n\u2705 Controls blood sugar levels<br \/>\n\u2705 Supports insulin sensitivity<br \/>\n\u2705 Minimizes diabetes-related complications<\/h5>\n<p><span style=\"color: #999999;\">Glycomet-GP contains Metformin and Glimepiride<\/span><\/p>\n","protected":false},"featured_media":50638,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3251,3254,3255],"class_list":{"0":"post-50637","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glimepiride","11":"product_tag-glycomet-gp","12":"product_tag-metformin","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product\/50637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/comments?post=50637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media\/50638"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/media?parent=50637"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_brand?post=50637"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_cat?post=50637"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/wp-json\/wp\/v2\/product_tag?post=50637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}